NCT00325780

Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

Open-Label, Long-Term (1 Year) Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 1,355 (actual)
• Sponsor: Kowa Research Europe · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This study is a long-term follow-up protocol for patients who participated in study NK-104-3.01EU or study NK-104-3.02EU.

Detailed description

Patients from the NK-104-3.01EU and NK-104-3.02EU studies will continue to receive either pitavastatin or the comparator statin for 1 year.

Conditions

• Hypercholesterolemia
• Dyslipidemia

Interventions

Type	Name	Description
DRUG	Pitavastatin	Pitavastatin 4 mg once daily

Timeline

• Start date: 2006-07-01
• Primary completion: 2007-11-01
• Completion: 2007-11-01
• First posted: 2006-05-15
• Last updated: 2010-02-02
• Results posted: 2010-01-18

Locations

186 sites across 13 countries: Denmark, Finland, Germany, India, Israel, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, United Kingdom